| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 898.00K | — |
| Operating expense | — | — |
| Net income | -42.76M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TRDA returned +23.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -26.4% |
| 1 year | +23.3% |
| All-time high | $29.78 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TRDA would be worth today ›No. Entrada Therapeutics, Inc. has not paid a dividend in the past 12 months.
Entrada Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol TRDA.
Entrada Therapeutics, Inc. is part of the Healthcare sector.
Entrada Therapeutics, Inc. has a market cap of 294.75M USD, based on the latest quote.
Entrada Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.